HRMY

38.12

0.99% -0.38

Dopo l'orario di chiusura: 38.12

Harmony Biosciences Holdings Inc (HRMY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRMY Giù? Forum Previsione

Precedente Chiudi:

$38.50

Aprire:

$38.22

Volume 24 ore:

388.56K

Relative Volume:

0.47

Capitalizzazione di mercato:

$2.22B

Reddito:

$899.11M

Utile/perdita netta:

$145.62M

Rapporto P/E:

15.35

EPS:

2.4829

Flusso di cassa netto:

$322.54M

1 W Prestazione:

-0.76%

1M Prestazione:

+9.51%

6M Prestazione:

+5.86%

1 anno Prestazione:

+4.41%

Intervallo 1D:

$37.87

$38.45

Intervallo di 1 settimana:

$37.87

$40.15

Portata 52W:

$25.52

$40.87

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Nome

Harmony Biosciences Holdings Inc

Settore

Healthcare (1080)

Industria

Biotechnology (604)

Telefono

(484) 539-9800

Indirizzo

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Dipendente

293

Cinguettio

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

HRMY's Discussions on Twitter

Compare HRMY vs VRTX, REGN, ARGX, RVMD, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HRMY Harmony Biosciences Holdings Inc	38.12	2.32B	899.11M	145.62M	322.54M	2.4829
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-23	Downgrade	Deutsche Bank	Buy → Hold
2026-02-23	Downgrade	Truist	Buy → Hold
2026-02-11	Ripresa	UBS	Neutral
2025-07-21	Iniziato	Truist	Buy
2025-07-10	Ripresa	Goldman	Neutral
2025-06-02	Ripresa	Oppenheimer	Outperform
2025-02-11	Iniziato	Deutsche Bank	Buy
2024-12-17	Iniziato	H.C. Wainwright	Buy
2024-10-10	Ripresa	Raymond James	Outperform
2024-09-10	Iniziato	UBS	Buy
2024-06-21	Iniziato	Citigroup	Buy
2024-01-02	Downgrade	BofA Securities	Neutral → Underperform
2023-09-25	Downgrade	Goldman	Neutral → Sell
2023-09-07	Iniziato	Berenberg	Buy
2023-04-20	Iniziato	BofA Securities	Neutral
2022-10-14	Aggiornamento	Janney	Neutral → Buy
2022-10-14	Aggiornamento	Jefferies	Hold → Buy
2022-08-03	Downgrade	Jefferies	Buy → Hold
2022-07-13	Downgrade	Goldman	Buy → Neutral
2022-07-07	Iniziato	Mizuho	Buy
2022-04-14	Iniziato	Cantor Fitzgerald	Overweight
2021-12-01	Iniziato	Oppenheimer	Outperform
2021-11-04	Iniziato	Raymond James	Outperform
2021-09-23	Iniziato	Needham	Buy
2021-03-29	Aggiornamento	Goldman	Neutral → Buy
2020-09-14	Iniziato	Goldman	Neutral
2020-09-14	Iniziato	Jefferies	Buy
2020-09-14	Iniziato	Piper Sandler	Overweight

Mostra tutto

Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie

Aug 14, 2026

Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline - marketbeat.com

Aug 14, 2026

Aug 13, 2026

HRMY: Record WAKIX sales drive CNS pipeline progress, with BP-205 and new pitolisant forms advancing - TradingView

Aug 13, 2026

Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Corbus Pharmaceuticals (CRBP) - The Globe and Mail

Aug 13, 2026

HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - Stocktwits

Aug 13, 2026

Zacks Research Downgrades Harmony Biosciences (NASDAQ:HRMY) to Hold - marketbeat.com

Aug 13, 2026

Aug 12, 2026

Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo Finance

Aug 12, 2026

Hennion & Walsh Asset Management Inc. Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY - marketbeat.com

Aug 12, 2026

Aug 11, 2026